Overall,ACUPA conjugated targeted starPEGs significantly improve tumor retentionwith deep tumor tissue penetration in low EPR PC3-Pip xenografts.These data suggest that PSMA targeting with multivalent ACUPA ligandsmay be a generally applicable strategy to increase nanocarrier deliveryto prostate cancer. Here, FOLH1 is linked to prostate cancer.